Qixun Chen

机构：Chinese Academy of Sciences, Zhejiang Cancer Hospital, Cancer Hospital of Chinese Academy of Medical Sciences, University of Chinese Academy of Sciences, Hangzhou Cancer Hospital, Nanjing University · ORCID：0000-0003-3941-780X

发表论文 98 篇 · 总被引 1741 次 · h-index 23

代表论文

• Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial (2024 · Nature Medicine · 被引 226)
• Clinical significance of preoperative CALLY index for prognostication in patients with esophageal squamous cell carcinoma undergoing surgery (2024 · Scientific Reports · 被引 68)
• Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial (2024 · Cancer Cell · 被引 59)
• Serum Protein Fishing for Machine Learning-Boosted Diagnostic Classification of Small Nodules of Lung (2024 · ACS Nano · 被引 32)
• Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study (2024 · Frontiers in Immunology · 被引 13)
• Personalized Cancer-Specific Protein-Aptamer Corona for Orthogonal Multiplex Cancer Diagnosis (2025 · Journal of the American Chemical Society · 被引 12)